BioSpace News Archive

The report is a result of a convening meeting held in December 2017 that brought together about 50 thought leaders.

Express Scripts is against clawbacks and gag clauses, anti-patient practices that have been used by other pharmacy benefit managers.

Thermo Fisher Scientific Inc. announced that it has acquired IntegenX Inc., which provides a rapid DNA platform for use in forensics and law enforcement applications.

Levocetirizine Dihydrochloride Tablets USP, 5 mg is an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing.

First and only subcutaneous immunoglobulin (SCIg) approved for the treatment of CIDP based on the largest controlled clinical study in CIDP

Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement

Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has partnered with Exosome Diagnostics, a privately held company focused on developing and commercializing revolutionary biofluid-based diagnostics, to design and validate an assay for use in Intezyne’s upcoming Phase 1/2 clinical trials of IT-139

LifeScan, Inc. is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion.

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that the Board of Directors has appointed Mr. Gregg Williams as Chairman of the Board, effective immediately

Industry Launch Meeting to Unveil ORTHO VISION® Platform of Immunohematology Analyzers